Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | PAM | P19021 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 3/20 | 0.48 |
| ▸ | CES1 | P23141 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 5/20 | 0.47 |
| ▸ | PPARG | P37231 | 6/20 | 0.46 |
| ▸ | PPARD | Q03181 | 6/20 | 0.46 |
| ▸ | PPARA | Q07869 | 6/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TLR2 | O60603 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | FABP4 | P15090 | 2/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.46 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5698805 | 1.00 | DGKA (0.55) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL8587852 | 1.00 | DGKA (0.55) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL5705163 | 1.00 | DGKA (0.55) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL7356015 | 0.98 | DGKA (0.52) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL7359360 | 0.91 | — | — | |
| SCHEMBL27490503 | 0.89 | MAPT (0.39) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL1712782 | 0.89 | MAPT (0.39) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL2261658 | 0.89 | MAPT (0.39) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL1712975 | 0.87 | TSHR (0.38) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL5157552 | 0.81 | HSD17B10 (0.54) | LMNAMAPTTSHRPPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3481383-B1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME | CELLIX BIO PRIVATE LTD (IN) | 2023-06-14 | — | — | EP | claimed |
| EP-0093548-B1 | CEPHALOSPORIN DERIVATIVES | Takeda Chemical Industries, Ltd. (JP) | 1986-12-30 | — | — | EP | claimed |
| US-9333181-B2 | Method for preparing functionalized lipid capsules | UNIVERSITE D'ANGERS (FR) | 2016-05-10 | — | — | US | disclosed |
| US-9333181-B2 | Method for preparing functionalized lipid capsules | UNIVERSITE D'ANGERS (FR) | 2016-05-10 | — | — | US | disclosed |
| EP-2413719-B1 | METHOD FOR PREPARING FUNCTIONALIZED LIPID CAPSULES | UNIV ANGERS (FR) | 2015-07-08 | — | — | EP | disclosed |
| US-20120148669-A1 | METHOD FOR PREPARING FUNCTIONALIZED LIPID CAPSULES | INS. NAT. DE LA SANTE ET DE LA RECHER MED (INSERM) (FR) | 2012-06-14 | — | — | US | disclosed |
| US-20120148669-A1 | METHOD FOR PREPARING FUNCTIONALIZED LIPID CAPSULES | INS. NAT. DE LA SANTE ET DE LA RECHER MED (INSERM) (FR) | 2012-06-14 | — | — | US | disclosed |
| WO-2010113111-A1 | METHOD FOR PREPARING FUNCTIONALIZED LIPID CAPSULES | UNIVERSITE D'ANGERS (FR) | 2010-10-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120148669-A1 | METHOD FOR PREPARING FUNCTIONALIZED LIPID CAPSULES | LCAT, LIPC, PLTP | DGKA 1473/4885LMNA 1401/4885PAM 351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.